2024: A Year of Growth and Foundations

As 2024 comes to an end, we look back on a transformative year for Suturion. It has been a time of progress, new collaborations, and laying a solid foundation for the future.

This year, we made strides in expanding our global reach. Distribution agreements were secured in Spain, Australia, and the GCC countries, while discussions continue with partners in Germany and France. Most notably, we are in promising negotiations with a U.S. partner, solidifying plans to bring SutureTOOL™ to one of the world’s largest and most important markets.  Our future strategic partner for the US market is a great and renowned organization and we hope to close the deal early Q1.

Our clinical and health-economic studies have been submitted for peer review, and we anticipate their publication in 2025. These efforts are key to our mission of bringing SutureTOOL to hospitals and patients worldwide.

Looking ahead, 2025 marks an exciting milestone as we prepare to launch SutureTOOL in three major regions: the USA, Europe, and the Middle East.

We thank our team, partners, and supporters for their dedication and wish everyone a happy holiday season and a prosperous New Year!

‍